Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea
- 1 December 2012
- journal article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 303 (11) , G1262-G1269
Abstract
Patients with irritable bowel syndrome (IBS) with diarrhea (IBS-D) carrying human leukocyte antigen (HLA)-DQ2/8 genotypes benefit from gluten withdrawal. Our objective was to compare gastrointestinal barrier function, mucosal inflammation, and transit in nonceliac IBS-D patients and assess association with HLA-DQ2/8 status. In 45 IBS-D patients who were naive to prior exclusion of dietary gluten, we measured small bowel (SB) and colonic mucosal permeability by cumulative urinary lactulose and mannitol excretion (0–2 h for SB and 8–24 h for colon), inflammation on duodenal and rectosigmoid mucosal biopsies (obtained in 28 of 45 patients), tight junction (TJ) protein mRNA and protein expression in SB and rectosigmoid mucosa, and gastrointestinal and colonic transit by validated scintigraphy. SB mucosal biopsies were stained with hematoxylin-eosin to assess villi and intraepithelial lymphocytes, and immunohistochemistry was used to assess CD3, CD8, tryptase, and zonula occludens 1 (ZO-1); colonic biopsy intraepithelial lymphocytes were quantitated. Associations of HLA-DQ were assessed using Wilcoxon's rank-sum test. Relative to healthy control data, we observed a significant increase in SB permeability (P < 0.001), a borderline increase in colonic permeability (P = 0.10), and a decrease in TJ mRNA expression in rectosigmoid mucosa in IBS-D. In HLA-DQ2/8-positive patients, ZO-1 protein expression in the rectosigmoid mucosa was reduced compared with that in HLA-DQ2/8-negative patients and colonic transit was slower than in HLA-DQ2/8-negative patients. No other associations with HLA genotype were identified. There is abnormal barrier function (increased SB permeability and reduced mRNA expression of TJ proteins) in IBS-D relative to health that may be, in part, related to immunogenotype, given reduced ZO-1 protein expression in rectosigmoid mucosa in HLA-DQ2/8-positive relative to HLA-DQ2/8-negative patients.Keywords
This publication has 37 references indexed in Scilit:
- Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controlsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- The Prevalence of Celiac Disease Among Patients With Nonconstipated Irritable Bowel Syndrome Is Similar to ControlsGastroenterology, 2011
- Redistribution of the tight junction protein ZO-1 during physiological shedding of mouse intestinal epithelial cellsAmerican Journal of Physiology-Cell Physiology, 2011
- Wireless pH‐motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipationNeurogastroenterology & Motility, 2010
- Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functionsNeurogastroenterology & Motility, 2010
- Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohortNeurogastroenterology & Motility, 2010
- Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretionNeurogastroenterology & Motility, 2009
- Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3Gastroenterology, 2008
- Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2008
- Alterations in Mucosal Immunity Identified in the Colon of Patients With Irritable Bowel SyndromeClinical Gastroenterology and Hepatology, 2008